Back to full study details
New York, NYNow Enrolling

Systemic Sclerosis Clinical Trial in New York, NY

Access cutting-edge systemic sclerosis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Expert Care

Access systemic sclerosis specialists in New York at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related systemic sclerosis treatment provided free

About This Systemic Sclerosis Study in New York

RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T cell therapy, in Subjects with Systemic Sclerosis

Sponsor: Cabaletta Bio

Apply for This New York Location

Check if you qualify for this systemic sclerosis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Systemic Sclerosis Treatment Options in New York, NY

If you're searching for systemic sclerosis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced systemic sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Why Consider a Clinical Trial for Systemic Sclerosis?

  • Access to new treatments before they're widely available
  • Receive care from leading systemic sclerosis specialists in New York
  • Contribute to medical research that could help future patients
  • Study-related care is typically provided at no cost
  • Close monitoring by a dedicated research team
  • Possible compensation for time and travel